{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:20Z","timestamp":1790835140178,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2016\/21\/B\/NZ7\/01131"],"award-info":[{"award-number":["2016\/21\/B\/NZ7\/01131"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"name":"POWR","award":["03.02.00-00-I013\/1"],"award-info":[{"award-number":["03.02.00-00-I013\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12640-019-00033-x","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T12:41:55Z","timestamp":1555332115000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats"],"prefix":"10.1007","volume":"36","author":[{"given":"Monika","family":"Herian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wojtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u015awit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Go\u0142embiowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"33_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0893-133X(98)00046-3","volume":"20","author":"WM Abi-Saab","year":"1999","unstructured":"Abi-Saab WM, Bubser M, Roth RH, Deutch AY (1999) 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 20:96. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(98)00046-3","journal-title":"Neuropsychopharmacology"},{"key":"33_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/00223980.1956.9916206","volume":"41","author":"H Abramson","year":"1956","unstructured":"Abramson H, Jarvik M, Govin M, Hirsch M (1956) Lysergic acid diethylamide (LSD-25): XVIII. Tolerance development and is relationship to a theory of psychosis. J Psychol 41:81\u2013105. \n                    https:\/\/doi.org\/10.1080\/00223980.1955.9916156","journal-title":"J Psychol"},{"key":"33_CR3","first-page":"619","volume":"1","author":"GK Aghajanian","year":"1975","unstructured":"Aghajanian GK, Haigler HJ (1975) Hallucinogenic indoleamines: oreferential action upon presynaptic serotonin receptors. Psychopharmacol Commun 1:619\u2013629","journal-title":"Psychopharmacol Commun"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","volume":"36","author":"GK Aghajanian","year":"1997","unstructured":"Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589\u2013599. \n                    https:\/\/doi.org\/10.1016\/S0028-3908(97)00051-8","journal-title":"Neuropharmacology"},{"key":"33_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5539\/gjhs.v9n11p126","volume":"9","author":"A Al-Imam","year":"2017","unstructured":"Al-Imam A, Abdul Majeed BA (2017) NBOMe compounds: systematic review and data crunching of the surface web. Global J Health Sci 9:126\u2013139. \n                    https:\/\/doi.org\/10.5539\/gjhs.v9n11p126","journal-title":"Global J Health Sci"},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2015.03.012","volume":"251","author":"MF Andreasen","year":"2015","unstructured":"Andreasen MF, Telving R, Rosendal I, Eg MB, Hasselstrom JB, Andersen LV (2015) A fatal poisoning involving 25C-NBOMe. Forensic Sci Int 251:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2015.03.012","journal-title":"Forensic Sci Int"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00421802","volume":"36","author":"B Angrist","year":"1974","unstructured":"Angrist B, Rotrosen J, Gershon S (1974) Assessment of tolerance to the hallucinogenic effects of DOM. Psychopharmacologia 36:203\u2013207. \n                    https:\/\/doi.org\/10.1007\/BF00421802","journal-title":"Psychopharmacologia"},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0006-8993(02)03727-7","volume":"959","author":"S Aznar","year":"2003","unstructured":"Aznar S, Qian Z, Shah R, Rahbek B, Knudsen GM (2003) The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 959:58\u201376. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(02)03727-7","journal-title":"Brain Res"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7854_2016_53","volume":"32","author":"MH Baumann","year":"2017","unstructured":"Baumann MH, Glennon RA, Wiley JL (2017) Neuropharmacology of new psychoactive substances. Curr Top Behav Neurosci 32:93\u2013117. \n                    https:\/\/doi.org\/10.1007\/7854_2016_53","journal-title":"Curr Top Behav Neurosci"},{"key":"33_CR10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/mol.106.028720","volume":"70","author":"MR Braden","year":"2006","unstructured":"Braden MR, Parrish JC, Naylor JC, Nichols DE (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol 70:1956\u20131964. \n                    https:\/\/doi.org\/10.1124\/mol.106.028720","journal-title":"Mol Pharmacol"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00213-010-1784-0","volume":"209","author":"CE Canal","year":"2010","unstructured":"Canal CE, Olaghere de Silva UB, Gresh PJ, Watt EE, Sanders-Bush E, Airey DC (2010) The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenylethylamine hallucinogen. Psychopharmacology (Berl) 209:163\u2013174. \n                    https:\/\/doi.org\/10.1007\/s00213-010-1784-0","journal-title":"Psychopharmacology (Berl)"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnint.2013.00025","volume":"7","author":"P Celada","year":"2013","unstructured":"Celada P, Puig MV, Artigas F (2013) Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 7:1\u201320. \n                    https:\/\/doi.org\/10.3389\/fnint.2013.00025","journal-title":"Front Integr Neurosci"},{"key":"33_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0028-3908(99)00086-6","volume":"39","author":"DA Clement","year":"2000","unstructured":"Clement DA, Punhani T, Duxon MS, Blackburn TP, Fone KC (2000) Immunohistochemical localization of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39:123\u2013132. \n                    https:\/\/doi.org\/10.1016\/S0028-3908(99)00086-6","journal-title":"Neuropharmacology"},{"key":"33_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P","volume":"409","author":"V Cornea-H\u00e9bert","year":"1999","unstructured":"Cornea-H\u00e9bert V, Riad M, Wu C, Singh SK, Descarries L (1999) Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187\u2013209. \n                    https:\/\/doi.org\/10.1002\/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P","journal-title":"J Comp Neurol"},{"key":"33_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","volume":"116","author":"NV Cozzi","year":"2009","unstructured":"Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE (2009) Dimethyltyptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116:1591\u20131599. \n                    https:\/\/doi.org\/10.1007\/s00702-009-0308","journal-title":"J Neural Transm"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0079-6123(08)00902-3","volume":"172","author":"V Mateo Di","year":"2008","unstructured":"Di Mateo V, Di Giovanni G, Pierucci M, Esposito E (2008) Serotonin control of central dopaminergic function: focus in in vivo microdialysis studies. Prog Brain Res 172:7\u201344. \n                    https:\/\/doi.org\/10.1016\/S0079-6123(08)00902-3","journal-title":"Prog Brain Res"},{"key":"33_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuropharm.2018.02.033","volume":"142","author":"JS Elmore","year":"2018","unstructured":"Elmore JS, Decker AM, Sulima A, Rice KC, Partilla JS, Blough BE, Baumann MH (2018) Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. Neuropharmacology 142:240\u2013250. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.033","journal-title":"Neuropharmacology"},{"key":"33_CR18","unstructured":"EMCDDA (2018) European drug report. Trends and developments. \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/8585\/20181816_TDAT18001ENN_PDF.pdf\n                    \n                  . Accessed 15 Oct 2018"},{"key":"33_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1124\/jpet.110.172247","volume":"335","author":"WE Fantegrossi","year":"2010","unstructured":"Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH (2010) Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. J Pharmacol Exp Ther 335:728\u2013734. \n                    https:\/\/doi.org\/10.1124\/jpet.110.172247","journal-title":"J Pharmacol Exp Ther"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/FBP.0000000000000309","volume":"28","author":"MB Gatch","year":"2017","unstructured":"Gatch MB, Dolan SB, Forster MJ (2017) Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behav Pharmacol 28:375\u2013385. \n                    https:\/\/doi.org\/10.1097\/FBP.0000000000000309","journal-title":"Behav Pharmacol"},{"key":"33_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/15563650.2015.1115056","volume":"54","author":"P Gee","year":"2016","unstructured":"Gee P, Schep LJ, Jensen BP, Moore G, Barrington S (2016) Case series: toxicity from 25B-NBOMe - a cluster of N-bomb cases. Clin Toxicol (Phila) 54:141\u2013146. \n                    https:\/\/doi.org\/10.3109\/15563650.2015.1115056","journal-title":"Clin Toxicol (Phila)"},{"key":"33_CR22","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505\u20132511. \n                    https:\/\/doi.org\/10.1016\/0024-3205(84)90436-3","journal-title":"Life Sci"},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(73)90206-9","volume":"21","author":"HJ Haigler","year":"1973","unstructured":"Haigler HJ, Aghajanian GK (1973) Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain. Eur J Pharmacol 21:53\u201360. \n                    https:\/\/doi.org\/10.1016\/0014-2999(73)90206-9","journal-title":"Eur J Pharmacol"},{"key":"33_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","volume":"277","author":"AL Halberstadt","year":"2015","unstructured":"Halberstadt AL (2015) Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 277:99\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2014.07.016","journal-title":"Behav Brain Res"},{"key":"33_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/7854_2016_64","volume":"32","author":"AL Halberstadt","year":"2017","unstructured":"Halberstadt AL (2017) Pharmacology and toxicology of N-benzylphenethylamine (\u201cNBOMe\u201d) hallucinogens. Curr Top Behav Neurosci 32:283\u2013311. \n                    https:\/\/doi.org\/10.1016\/j.cub.2016.12.058","journal-title":"Curr Top Behav Neurosci"},{"key":"33_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","volume":"61","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61:364\u2013381. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01017","journal-title":"Neuropharmacology"},{"key":"33_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","volume":"77","author":"AL Halberstadt","year":"2014","unstructured":"Halberstadt AL, Geyer MA (2014) Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology 77:200\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.025","journal-title":"Neuropharmacology"},{"key":"33_CR28","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/npp.2009.29","volume":"34","author":"AL Halberstadt","year":"2009","unstructured":"Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB (2009) 5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 34:1958\u20131967. \n                    https:\/\/doi.org\/10.1038\/npp.2009.29","journal-title":"Neuropsychopharmacology"},{"key":"33_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/15563650.2011.615318","volume":"49","author":"SL Hill","year":"2011","unstructured":"Hill SL, Thomas SHL (2011) Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 49:705\u2013719. \n                    https:\/\/doi.org\/10.3109\/15563650.2011.615318","journal-title":"Clin Toxicol (Phila)"},{"key":"33_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuropharm.2018.02.028","volume":"142","author":"LM Klein","year":"2018","unstructured":"Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL (2018) Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmaology 142:231\u2013239. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.028","journal-title":"Neuropharmaology"},{"key":"33_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.forsciint.2015.02.010","volume":"249","author":"VB Kueppers","year":"2015","unstructured":"Kueppers VB, Cooke CT (2015) 25I-NBOMe related death in Australia: a case report. Forensic Sci Int 249:15\u201318. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2015.02.010","journal-title":"Forensic Sci Int"},{"key":"33_CR32","first-page":"3270","volume":"19","author":"C Kyriakou","year":"2015","unstructured":"Kyriakou C, Marinelli E, Frati P, Santurro A, Afxentiou M, Zaami S, Busardo FP (2015) NBOMe: new potent hallucinogens \u2013 pharmacology, analytical methods, toxicities, fatalities: a review. Eur Rev Med Pharmacol Sci 19:3270\u20133281","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"33_CR33","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.neuroscience.2007.02.064","volume":"146","author":"S Liu","year":"2007","unstructured":"Liu S, Bubar MJ, Lanfranco MF, Hillman GR, Cunningham KA (2007) Serotonin 2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 146:1677\u20131688. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2007.02.064","journal-title":"Neuroscience"},{"key":"33_CR34","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","volume":"21","author":"R Mart\u00edn-Ruiz","year":"2001","unstructured":"Mart\u00edn-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856\u20139866. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.21-24-09856.2001","journal-title":"J Neurosci"},{"key":"33_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2004.07.044","volume":"1023","author":"JW Muschamp","year":"2004","unstructured":"Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA (2004) Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res 1023:134\u2013140. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2004.07.044","journal-title":"Brain Res"},{"key":"33_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132\u2013137. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.075","journal-title":"Eur J Pharmacol"},{"key":"33_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2003.11.002","journal-title":"Pharmacol Ther"},{"key":"33_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/wmts.42","volume":"1","author":"DE Nichols","year":"2012","unstructured":"Nichols DE (2012) Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr Transp Signal 1:559\u2013579. \n                    https:\/\/doi.org\/10.1002\/wmts.42","journal-title":"WIREs Membr Transp Signal"},{"key":"33_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. \n                    https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"key":"33_CR40","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/cn500292d","volume":"6","author":"DE Nichols","year":"2015","unstructured":"Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, Fiedler WJ (2015) N-Benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with series of phenethylamine analogues. ACS Chem Neurosci 6:1165\u20131175. \n                    https:\/\/doi.org\/10.1021\/cn500292d","journal-title":"ACS Chem Neurosci"},{"key":"33_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/01480545.2014.911882","volume":"38","author":"P Nikolaou","year":"2015","unstructured":"Nikolaou P, Papoutsis I, Stefanidou M, Spiliopoulou C, Athanaselis S (2015) 2C-I-NBOMe, an \u201cN-bomb\u201d that kills with \u201cSmiles\u201d. Toxicological and legislative aspects. Drug Chem Toxicol 38:113\u2013119. \n                    https:\/\/doi.org\/10.3109\/01480545.2014.911882","journal-title":"Drug Chem Toxicol"},{"key":"33_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","volume":"111","author":"C Nocjar","year":"2002","unstructured":"Nocjar C, Roth BL, Pehek EA (2002) Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111:163\u2013176. \n                    https:\/\/doi.org\/10.1016\/S0306-4522(01)00593-0","journal-title":"Neuroscience"},{"key":"33_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s12640-016-9654-0","volume":"30","author":"K Noworyta-Soko\u0142owska","year":"2016","unstructured":"Noworyta-Soko\u0142owska K, Kami\u0144ska K, Kreiner G, Rog\u00f3\u017c Z, Go\u0142embiowska K (2016) Neurotoxic effects of 5-MeO-DIPT: a psychoactive tryptamine derivative in rats. Neurotox Res 30:606\u2013619. \n                    https:\/\/doi.org\/10.1007\/s12640-016-9654-0","journal-title":"Neurotox Res"},{"key":"33_CR44","doi-asserted-by":"publisher","unstructured":"Noworyta-Soko\u0142owska K, Kami\u0144ska K, Rzemieniec J, Wnuk A, Wojcieszak J, G\u00f3rska AM, Kreiner G, Kajta M, Go\u0142embiowska K (2019) Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats. Forensic Toxicol 37:45\u201358. \n                    https:\/\/doi.org\/10.1007\/s11419-018-0433-x","DOI":"10.1007\/s11419-018-0433-x"},{"key":"33_CR45","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic Press, Cambridge"},{"key":"33_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0006-8993(00)03004-3","volume":"888","author":"EA Pehek","year":"2001","unstructured":"Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51\u201359. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(00)03004-3","journal-title":"Brain Res"},{"key":"33_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF00443425","volume":"97","author":"PA Pierce","year":"1989","unstructured":"Pierce PA, Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118\u2013122. \n                    https:\/\/doi.org\/10.1007\/BF00443425","journal-title":"Psychopharmacology"},{"key":"33_CR48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jat\/bkv073","volume":"39","author":"JL Poklis","year":"2015","unstructured":"Poklis JL, Raso SA, Alford KN, Poklis A, Peace MR (2015) Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl) methyl]ethanamine derivatives on blotter paper. J Anal Toxicol 39:617\u2013623. \n                    https:\/\/doi.org\/10.1093\/jat\/bkv073","journal-title":"J Anal Toxicol"},{"key":"33_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","volume":"23","author":"M Pompeiano","year":"1994","unstructured":"Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2A receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23:163\u2013178. \n                    https:\/\/doi.org\/10.1016\/0169-328X(94)90223-2","journal-title":"Brain Res Mol Brain Res"},{"key":"33_CR50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","volume":"13","author":"MV Puig","year":"2003","unstructured":"Puig MV, Celada P, Diaz-Matix L, Artigas F (2003) In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex 13:870\u2013882. \n                    https:\/\/doi.org\/10.1093\/cencor\/13.8.870","journal-title":"Cereb Cortex"},{"key":"33_CR51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","volume":"99","author":"A Rickli","year":"2015","unstructured":"Rickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99:546\u2013553. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.034","journal-title":"Neuropharmacology"},{"key":"33_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/15563650.2013.772191","volume":"51","author":"SR Rose","year":"2013","unstructured":"Rose SR, Poklis JL, Poklis A (2013) A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila) 51:174\u2013177. \n                    https:\/\/doi.org\/10.3109\/15563650.2013.772191","journal-title":"Clin Toxicol (Phila)"},{"key":"33_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-0270(94)00132-Z","volume":"57","author":"HL Rowley","year":"1995","unstructured":"Rowley HL, Martin KF, Marsden CA (1995) Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatization. J Neurosci Methods 57:93\u201399. \n                    https:\/\/doi.org\/10.1016\/0165-0270(94)00132-z","journal-title":"J Neurosci Methods"},{"key":"33_CR54","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","volume":"14","author":"N Santana","year":"2004","unstructured":"Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotonin 1A and serotonin 2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100\u20131109. \n                    https:\/\/doi.org\/10.1093\/cencor\/bhh070","journal-title":"Cereb Cortex"},{"key":"33_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2806799","volume-title":"Plants of the gods: their sacred, healing, and hallucinogenic powers","author":"RE Schultes","year":"1998","unstructured":"Schultes RE, Hofmann A, R\u00e4tsch C (1998) Plants of the gods: their sacred, healing, and hallucinogenic powers. Healing Art Press, Rochester, pp 1\u2013208. \n                    https:\/\/doi.org\/10.2307\/2806799"},{"key":"33_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","volume":"346","author":"JL Scruggs","year":"2003","unstructured":"Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137\u2013140. \n                    https:\/\/doi.org\/10.1016\/S0304-3940(03)00547-0","journal-title":"Neurosci Lett"},{"key":"33_CR57","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/jat\/bkv058","volume":"39","author":"KG Shanks","year":"2015","unstructured":"Shanks KG, Sozio T, Behonick GS (2015) Fatal intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014. J Anal Toxicol 39:602\u2013606. \n                    https:\/\/doi.org\/10.1093\/jat\/bkv058","journal-title":"J Anal Toxicol"},{"key":"33_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/00008877-199512000-00010","volume":"6","author":"TA Sipes","year":"1995","unstructured":"Sipes TA, Geyer MA (1995) DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors. Behav Pharmacol 6:839\u2013842. \n                    https:\/\/doi.org\/10.1097\/00008877-199512000-00010","journal-title":"Behav Pharmacol"},{"key":"33_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jchemneu.2011.04.004","volume":"41","author":"M Soiza-Reilly","year":"2011","unstructured":"Soiza-Reilly M, Commons KG (2011) Glutamatergic drive of the dorsal raphe nucleus. J Chem Neuroanat 41:247\u2013255. \n                    https:\/\/doi.org\/10.1016\/j.jchemneu.2011.04.004","journal-title":"J Chem Neuroanat"},{"key":"33_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","volume":"56","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion, a novel class of potent hallucinogens: a review of the literature. Psychosomatics 56:129\u2013139. \n                    https:\/\/doi.org\/10.1016\/j.psym.2014.11.002","journal-title":"Psychosomatics"},{"key":"33_CR61","doi-asserted-by":"publisher","unstructured":"UNODC Report (2013). World drug report. United Nations publication. \n                    https:\/\/www.unodc.org\/wdr2017\/field\/Booklet_4_ATSNPS.pdf\n                    \n                   . Sales No. E. 13.XI.6 (Vol. 2013). \n                    https:\/\/doi.org\/10.1002\/yd.20002","DOI":"10.1002\/yd.20002"},{"key":"33_CR62","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0091-3057(01)00552-4","volume":"69","author":"SP Vickers","year":"2001","unstructured":"Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA (2001) Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69:643\u2013652. \n                    https:\/\/doi.org\/10.1016\/S0091-3057(01)00552-4","journal-title":"Pharmacol Biochem Behav"},{"key":"33_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","volume":"35","author":"JP Walterscheid","year":"2014","unstructured":"Walterscheid JP, Phillips GT, Lopez AE, Gonsoulin ML, Chen HH, Sanchez LA (2014) Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. Am J Forensic Med Pathol 35:20\u201325. \n                    https:\/\/doi.org\/10.1097\/PAF.0000000000000082","journal-title":"Am J Forensic Med Pathol"},{"key":"33_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF02244617","volume":"100","author":"LL Wing","year":"1990","unstructured":"Wing LL, Tapson GS, Geyer MA (1990) 5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology 100:417\u2013425. \n                    https:\/\/doi.org\/10.1007\/bf02244617","journal-title":"Psychopharmacology"},{"key":"33_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00413101","volume":"14","author":"AB Wolbach","year":"1962","unstructured":"Wolbach AB, Isbell H, Miner EJ (1962) Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacologia 14:1\u201314. \n                    https:\/\/doi.org\/10.1007\/bf00413101","journal-title":"Psychopharmacologia"},{"key":"33_CR66","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1152\/jn.1999.82.6.2989","volume":"82","author":"FM Zhou","year":"1999","unstructured":"Zhou FM, Hablitz JJ (1999) Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82:2989\u20132999. \n                    https:\/\/doi.org\/10.1152\/jn.1999.82.6.2989","journal-title":"J Neurophysiol"},{"key":"33_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.forsciint.2012.08.027","volume":"227","author":"D Zuba","year":"2013","unstructured":"Zuba D, Seku\u0142a K, Buczek A (2013) 25C-NBOMe - new potent hallucinogenic substance identified on the drug market. Forensic Sci Int 227:7\u201314. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2012.08.027","journal-title":"Forensic Sci Int"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00033-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:58:32Z","timestamp":1586822312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00033-x","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The use of adult male rats for the experiments was approved by the Local Ethical Commission for Experimentations on Animals in Krak\u00f3w. This article does not contain any studies with human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}